Course: Quality of Life of Patients with Rare Diseases

« Back
Course title Quality of Life of Patients with Rare Diseases
Course code USV/EQLPA
Organizational form of instruction Lecture
Level of course unspecified
Year of study not specified
Semester Winter
Number of ECTS credits 3
Language of instruction English
Status of course unspecified
Form of instruction Face-to-face
Work placements This is not an internship
Recommended optional programme components None
Course availability The course is available to visiting students
Lecturer(s)
  • Kočová Helena, Mgr. Ph.D.
Course content
1. Target group of children, adolescents and adult patients with rare diseases - description and types of diseases, course of progression and treatment in multidisciplinary care and teamwork 2. EURORDIS is attracting an increasing number of patient organisations outside of Europe and is gaining traction at promoting rare diseases at the international level. "Orphan drugs" are medicinal products intended for diagnosis, prevention or treatment of life-threatening or debilitating rare diseases. 3. Czech Association for Rare Diseases and Early Diagnosis, Psychosocial Support, Treatment and Sharing Good Practice. EU and Czech policy and rare diseases. Specialized centers - European Reference Networks (ERN). 4. Spinal muscular atrophy, Muscular dystrophy, treatment, Newborn screening and Quality of life and 5. Alternative and augmentative communication in the most difficult types of RD, home lung ventilation and tracheostomy, supportive aids for communication. 6. Palliative care for patients with RD

Learning activities and teaching methods
Dialogic (discussion, interview, brainstorming), Activating (simulations, games, drama), Individual preparation for exam, Individual tutoring
  • Preparation for classes - 30 hours per semester
  • Class attendance - 5 hours per semester
Learning outcomes
Target group of children, adolescents and adult patients with rare diseases - description and types of diseases, course of progression and treatment in multidisciplinary care and teamwork. EURORDIS is attracting an increasing number of patient organisations outside of Europe and is gaining traction at promoting rare diseases at the international level. "Orphan drugs" are medicinal products intended for diagnosis, prevention or treatment of life-threatening or debilitating rare diseases.
It is assumed that the acquired knowledge and knowledge about the problem of various diseases will be used in practice
Prerequisites
An active interest in the issue of various diseases in context is assumed

Assessment methods and criteria
Oral examination, Student performance assessment, Interview, Systematic student observation, Seminar work

Presentation on the topic of rare diseases and oral exam.
Recommended literature
  • BRADLYN,A.S;VARNI,J.W;HINDS,P.S. Assessing Healted-related Quality of Life in end of Life Care for CHildern And Adolescents. 2003.
  • Cohen, J. S. , and Biesecker B. B.. Quality of life in rare genetic conditions: a systematic review. .
  • KOCOVA,H. Dvorackova,O.,Vondracek,P.,Haberlova,J. Health-Related Quality of Life in Children and Adolescents. Health-Related Quality of Life in Children and Adolescents With Spinal Muscular Atrophy in the Czech Republic. USA. 2014.
  • PELCHAT,D. ;LEFEBVRE,H. A holistic intervention programme for families with child with a disability. .
  • SCHROTH, M. Breathing basics. USA. 2006.
  • SIMONDS, A. Ethical aspects of home long term ventilation in children with neuromuscular disease. .


Study plans that include the course
Faculty Study plan (Version) Category of Branch/Specialization Recommended year of study Recommended semester